89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details

臨床試験数 : 39 / 薬物数 : 46 - (DrugBank : 20) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 137

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00989742 (ClinicalTrials.gov)	July 2009	2/10/2009	Doxycycline In Lymphangioleiomyomatosis (LAM)	A Randomised, Double Blind, Placebo Controlled Trial of Doxycycline in Lymphangioleiomyomatosis.	Lymphangioleiomyomatosis;Tuberous Sclerosis	Drug: Doxycycline;Drug: Placebo	University of Nottingham	NULL	Completed	18 Years	N/A	Female	24	Phase 4	United Kingdom
2	EUCTR2007-003745-32-GB (EUCTR)	12/12/2008	26/11/2010	A randomised, double blind, placebo controlled trial of doxycyclinein lymphangioleiomyomatosis. - Do ...	A randomised, double blind, placebo controlled trial of doxycyclinein lymphangioleiomyomatosis. - Do ...	Lymphangioleiomyomatosis MedDRA version: 9.1;Level: LLT;Classification code 10049459;Term: Lymphangi ...	Trade Name: Doxycycline 100 mg Capsules INN or Proposed INN: doxycycline	University of Nottingham	NULL	Not Recruiting			Female: yes Male: no			United Kingdom

First Previous1Next Last